Related Experiment Video
Updated: Jun 2, 2026

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
Class III β-tubulin counteracts the ability of paclitaxel to inhibit cell migration
Anutosh Ganguly1, Hailing Yang, Fernando Cabral
1Department of Integrative Biology and Pharmacology, University of Texas Medical School, Houston, Texas 77030, USA.
Abstract:
Class III β-tubulin (β3) is associated with tumor aggressiveness, resistance to therapy, and patient relapse. To elucidate its action, we tested β3's effect on cell migration. Expression of β3 in HeLa and MCF-7 did not alter the intrinsic rate of cell migration, but it prevented the inhibition of migration by low, nontoxic concentrations of paclitaxel. The effects on cell motility were confirmed in CHO cells with tetracycline regulated expression of β3. Cell migration and microtubule dynamics were inhibited by similar concentrations of paclitaxel, but required a 5-10 fold higher drug concentration when β3 was expressed. The directionality of migration was normal in paclitaxel, but cells spent more time in a "paused" state during which there was no net movement. These studies support a model in which paclitaxel inhibits cell migration by suppressing microtubule dynamics and β3-tubulin counteracts paclitaxel action by maintaining microtubule dynamic activity. The results provide a potential explanation for the aggressiveness of β3-expressing tumors.
Insights
Class III β-tubulin (β3) counteracts paclitaxel's inhibition of cell migration by maintaining microtubule dynamics. This finding may explain why tumors expressing β3 tubulin are more aggressive and resistant to therapy.
Area of Science:
- Cell Biology
- Cancer Biology
- Microtubule Dynamics
Background:
- Class III β-tubulin (β3) is linked to increased tumor aggressiveness, therapeutic resistance, and patient relapse.
- Understanding the molecular mechanisms of β3 tubulin's action is crucial for developing effective cancer treatments.
Purpose of the Study:
- To investigate the role of Class III β-tubulin (β3) in regulating cell migration, particularly in response to paclitaxel treatment.
- To elucidate how β3 tubulin influences microtubule dynamics and cell motility under chemotherapeutic stress.
Main Methods:
- Utilized HeLa, MCF-7, and CHO cell lines with varying expression levels of β3 tubulin.
- Assessed cell migration rates and directionality using live-cell imaging.
- Analyzed microtubule dynamics and response to paclitaxel at different β3 tubulin concentrations.
Main Results:
- β3 tubulin expression did not alter basal cell migration rates but conferred resistance to paclitaxel-induced migration inhibition.
- Paclitaxel inhibited cell migration and microtubule dynamics, an effect significantly reduced by β3 tubulin expression (5-10 fold higher concentration required).
- While paclitaxel affected migration directionality, β3 tubulin expression led to cells spending more time in a paused state.
Conclusions:
- β3 tubulin counteracts paclitaxel's inhibitory effects on cell migration by preserving microtubule dynamic instability.
- These findings suggest a mechanism by which β3 tubulin contributes to tumor aggressiveness and therapeutic resistance.
- Targeting β3 tubulin or its interaction with microtubules may offer new therapeutic strategies for aggressive cancers.
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Microtubules in Cell Motility
Destabilization of Microtubules
Microtubule Associated Proteins (MAPs)

